no code implementations • 5 Mar 2024 • Jacob Granley, Galen Pogoncheff, Alfonso Rodil, Leili Soo, Lily Marie Turkstra, Lucas Gil Nadolskis, Arantxa Alfaro Saez, Cristina Soto Sanchez, Eduardo Fernandez Jover, Michael Beyeler
Neural activity in the visual cortex of blind humans persists in the absence of visual stimuli.
1 code implementation • NeurIPS 2023 • Jacob Granley, Tristan Fauvel, Matthew Chalk, Michael Beyeler
We show that our approach quickly learns a personalized stimulus encoder, leads to dramatic improvements in the quality of restored vision, and is robust to noisy patient feedback and misspecifications in the underlying forward model.
no code implementations • 30 Nov 2022 • Melani Sanchez-Garcia, Tushar Chauhan, Benoit R. Cottereau, Michael Beyeler
In contrast, spiking neural networks (SNNs) have the potential to improve both the efficiency and biological plausibility of object recognition systems.
no code implementations • 27 Sep 2022 • Jacob Granley, Alexander Riedel, Michael Beyeler
Overall, this is an essential first step towards building brain-like models of electrical stimulation, which may not just improve the quality of vision provided by cortical prostheses but could also further our understanding of the neural code of vision.
no code implementations • 26 May 2022 • Jacob Granley, Lucas Relic, Michael Beyeler
Sensory neuroprostheses are emerging as a promising technology to restore lost sensory function or augment human capabilities.
no code implementations • 20 May 2022 • Melani Sanchez-Garcia, Tushar Chauhan, Benoit R. Cottereau, Michael Beyeler
Deep neural networks have surpassed human performance in key visual challenges such as object recognition, but require a large amount of energy, computation, and memory.
no code implementations • 10 Mar 2022 • Lucas Relic, BoWen Zhang, Yi-Lin Tuan, Michael Beyeler
Retinal implants have the potential to treat incurable blindness, yet the quality of the artificial vision they produce is still rudimentary.
no code implementations • 4 Mar 2022 • Ashley Bruce, Michael Beyeler
Visual neuroprostheses are the only FDA-approved technology for the treatment of retinal degenerative blindness.
1 code implementation • 9 Jul 2021 • Shuyun Tang, Ziming Qi, Jacob Granley, Michael Beyeler
The network consists of a novel bottleneck attention block that combines and refines self-attention, channel attention, and relative-position attention to highlight retinal abnormalities that may be important for fovea and OD segmentation in the degenerated retina.
Ranked #1 on Fovea Detection on REFUGE
1 code implementation • 30 Jan 2021 • Nicole Han, Sudhanshu Srivastava, Aiwen Xu, Devi Klein, Michael Beyeler
Retinal degenerative diseases cause profound visual impairment in more than 10 million people worldwide, and retinal prostheses are being developed to restore vision to these individuals.